RGS6 and depressive symptom measurement: RGS6 knockout in mice was found to inhibit anxiety and depression via serotonin-mediated activation of the 5-HT receptor-adenylyl cyclase axis51, suggesting that a gain of function of this gene might be implicated in neuropsychiatric phenotypes52.